These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Acquired cellular immunity: extracellular killing of Listeria monocytogenes by a product of immunologically activated macrophages. Bast RC; Cleveland RP; Littman BH; Zbar B; Rapp HJ Cell Immunol; 1974 Feb; 10(2):248-59. PubMed ID: 4218128 [No Abstract] [Full Text] [Related]
44. Contribution of macrophage arginase in the intrinsic restriction of herpes simplex virus replication in permissive macrophage cultures induced by gamma-interferon containing products of activated spleen cells. Sethi KK Immunobiology; 1983 Dec; 165(5):459-74. PubMed ID: 6319272 [TBL] [Abstract][Full Text] [Related]
45. The effect of Listeria monocytogenes lipids on the activity of nonspecific immune mechanisms. Jakoniuk P; Borowski J; Jabłońska-Strynkowska W Arch Immunol Ther Exp (Warsz); 1980; 28(4):611-8. PubMed ID: 6779775 [TBL] [Abstract][Full Text] [Related]
46. Comparison of herpes simplex virus type 1 DNA replication and virus production in murine bone marrow-derived and resident peritoneal macrophages. Leary K; Connor JR; Morahan PS J Gen Virol; 1985 May; 66 ( Pt 5)():1123-9. PubMed ID: 2987398 [TBL] [Abstract][Full Text] [Related]
47. Detection of IL-1 beta, TNF-alpha, and IL-6 gene transcription by the polymerase chain reaction in keratinocytes, Langerhans cells and peritoneal exudate cells during infection with herpes simplex virus-1. Sprecher E; Becker Y Arch Virol; 1992; 126(1-4):253-69. PubMed ID: 1326263 [TBL] [Abstract][Full Text] [Related]
48. Comparison of antiviral and antitumor activity of activated macrophages. Morahan PS; Glasgow LA; Crane JL; Kern ER Cell Immunol; 1977 Feb; 28(2):404-15. PubMed ID: 191199 [No Abstract] [Full Text] [Related]
49. Effect of Bacillus Calmette-Guérin infection on delayed footpad reaction to Listeria monocytogenes. Yoshikai Y; Miake S; Koga T; Watanabe Y; Nomoto K Cell Immunol; 1984 Feb; 83(2):404-13. PubMed ID: 6420081 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of the in vitro-reactivation of latent herpes simplex virus infection in spinal ganglia: comparison of various immune factors. Brief report. von Rheinbaben F; Schneweis KE Arch Virol; 1986; 87(3-4):315-9. PubMed ID: 2418807 [TBL] [Abstract][Full Text] [Related]
51. Induction of cytotoxic T lymphocytes against herpes simplex virus type i: role of accessory cells and amplifying factor. Rouse BT; Lawman MJ J Immunol; 1980 May; 124(5):2341-6. PubMed ID: 6245140 [TBL] [Abstract][Full Text] [Related]
52. The role of macrophages and macrophage cytokines in host resistance to herpes simplex virus. Hendrzak JA; Morahan PS Immunol Ser; 1994; 60():601-17. PubMed ID: 7504529 [No Abstract] [Full Text] [Related]
54. Effects of bacterial products on lymphocytes and macrophages: their possible role in natural resistance to listeria infetion in mice. Petit JC; Unanue ER J Immunol; 1974 Sep; 113(3):984-92. PubMed ID: 4213069 [No Abstract] [Full Text] [Related]
55. In vitro stimulation of rabbit T lymphocytes by cells expressing herpes simplex antigens. Kapoor AK; Ling NR; Nash AA; Bachan A; Wildy P J Gen Virol; 1982 Apr; 59(Pt 2):415-9. PubMed ID: 6281376 [TBL] [Abstract][Full Text] [Related]